Cancer Chemotherapy and Pharmacology

230.6k citations
9.0k papers · · active since 1950

Impact in

  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • Drug Transport and Resistance Mechanisms
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Research Studies

Papers in

    • Cancer Treatment and Pharmacology 793
    • Drug Transport and Resistance Mechanisms 408
    • Colorectal Cancer Treatments and Studies 406
    • Lung Cancer Research Studies 355

Cancer Chemotherapy and Pharmacology

7.0k papers receiving 176.4k citations

Peers

Cancer Chemotherapy and Pharmacology
Comparison fields: 5 of 217
  • Oncology 77.8k
  • Cancer Research 22.2k
  • Molecular Biology 83.1k
  • Hematology 12.1k
  • Pathology and Forensic Medicine 18.4k
Replace Molecular Cancer Therapeutics with:
Molecular Cancer Therapeutics United States
Journal of Leukocyte Biology United States
Journal of Immunological Methods United States
Clinica Chimica Acta United States
World Journal of Gastroenterology China
Drugs United States
International Journal of Oncology United States
Nature reviews. Immunology United States
Frontiers in Pharmacology China
Nature Reviews Drug Discovery United States
Cancer Chemotherapy and Pharmacology relative to Molecular Cancer Therapeutics United States Molecular Cancer Therapeutics's profile →
Citations per field
00.5×1.5×
Molecular Cancer Therapeutics · 1×
Citations per year

Countries where authors publish in Cancer Chemotherapy and Pharmacology

Since Specialization
Citations

This map shows the geographic impact of research published in Cancer Chemotherapy and Pharmacology. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Cancer Chemotherapy and Pharmacology with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cancer Chemotherapy and Pharmacology more than expected).

Fields of papers published in Cancer Chemotherapy and Pharmacology

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Cancer Chemotherapy and Pharmacology. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Cancer Chemotherapy and Pharmacology.

About Cancer Chemotherapy and Pharmacology

The 9.0k papers published in Cancer Chemotherapy and Pharmacology in the last decades have received a total of 230.6k indexed citations . Papers published in Cancer Chemotherapy and Pharmacology usually cover Oncology (2.7k papers), Hematology (505 papers), Pathology and Forensic Medicine (664 papers), Pulmonary and Respiratory Medicine (1.1k papers) and Genetics (354 papers) specifically the topics of Cancer therapeutics and mechanisms (831 papers), Cancer Treatment and Pharmacology (793 papers), Chemotherapy-induced organ toxicity mitigation (424 papers), Drug Transport and Resistance Mechanisms (408 papers), Colorectal Cancer Treatments and Studies (406 papers), Lung Cancer Treatments and Mutations (373 papers), Acute Lymphoblastic Leukemia research (357 papers) and Lung Cancer Research Studies (355 papers). The most active scholars publishing in Cancer Chemotherapy and Pharmacology are C. Patrick Reynolds, Mary M. Tomayko, Howard A. Burris, Victor Ling, Paul H. Sugarbaker, Ganna V. Kalayda, Susan P.C. Cole, David E. Kleiner, William G. Stetler‐Stevenson and Branimir I. Šikić.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact